Medicare told to reassess premium hike after price slashed on Biogen Alzheimer's drug
January 10, 2022 at 17:29 PM EST
Department of Health and Human Services Secretary Xavier Becerra has asked Medicare to reassess its 2022 premium increase after Biogen slashed the cost of its expensive new Alzheimer's drug, which was part of the reason for the boost.
